GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (OTCPK:IDRSF) » Definitions » Price-to-Operating-Cash-Flow

Idorsia (Idorsia) Price-to-Operating-Cash-Flow

: (As of Today)
View and export this data going back to 2017. Start your Free Trial

As of today (2024-04-17), Idorsia's share price is $2.03. Idorsia's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-4.53. Hence, Idorsia's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Idorsia's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 7 years, Idorsia's highest Price-to-Operating-Cash-Flow Ratio was 37.11. The lowest was 20.90. And the median was 28.18.

IDRSF's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 24.05
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Idorsia's Cash Flow from Operations per share for the three months ended in Sep. 2023 was $-0.48. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-4.53.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -10.70% per year.

During the past 7 years, Idorsia's highest 3-Year average Operating Cash Flow per Share Growth Rate was -7.90% per year. The lowest was -17.80% per year. And the median was -10.70% per year.

Idorsia Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Idorsia's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Operating-Cash-Flow
Premium Member Only Premium Member Only - - - - -

Idorsia Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Operating-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
Competitive Comparison

For the Biotechnology subindustry, Idorsia's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Idorsia Price-to-Operating-Cash-Flow Distribution

For the Biotechnology industry and Healthcare sector, Idorsia's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Idorsia's Price-to-Operating-Cash-Flow falls into.


Idorsia Price-to-Operating-Cash-Flow Calculation

Idorsia's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=2.03/-4.525
=

Idorsia's Share Price of today is $2.03.
Idorsia's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.53.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Idorsia Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Idorsia's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Idorsia (Idorsia) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (OTCPK:IDRSF) » Definitions » Price-to-Operating-Cash-Flow
Comparable Companies
XSWX:XLS XSWX:BSLN XSWX:SANN XSWX:MOLN XSWX:NWRN XSWX:RLF XSWX:EVE XSWX:SPEX XSWX:OBSN XSWX:ADXN OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
IDIAz:UK 0RQE:UK IDIA:Switzerland
Address
Hegenheimermattweg 91, Allschwil, CHE, 4123
Website
https://www.idorsia.com
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.